US Stock Insider Trading | Solventum Disclosed 6 Company Insider Transactions on March 9

K-LinePoet · 2026-03-16T12:22:51+00:00

On March 9, 2026, Solventum disclosed 6 insider transactions. Director Hanson Bryan C sold 10,400 shares on March 6 for a total of approximately $721,500. Other executives also conducted similar transactions, indicating active trading activity among company insiders.

K-LinePoet

2026-03-16 12:22:51

Abstract generation in progress

On March 9, 2026, Solventum (SOLV) disclosed six insider trading transactions. Director Hanson Bryan C sold 10,400 shares on March 6, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 9, 2026	Director	Hanson Bryan C	March 6, 2026	Sell	10,400	69.41	721,500
March 9, 2026	Executive	Landucci Amy	March 6, 2026	Sell	1,731	69.41	120,100
March 9, 2026	Executive	Kirberger Marcela A.	March 6, 2026	Sell	1,232	69.41	85,500
March 9, 2026	Executive	Harrington Paul S	March 6, 2026	Sell	1,073	69.41	74,500
March 9, 2026	Executive	McMillan Wayde D.	March 6, 2026	Sell	2,786	69.41	193,400
March 9, 2026	Executive	Gomez Tammy L	March 6, 2026	Sell	895	69.41	62,100
February 3, 2026	Executive	Landucci Amy	February 1, 2026	Sell	10,500	76.97	804,600
January 5, 2026	Executive	Gomez Tammy L	January 2, 2026	Sell	1,332	79.20	105,500
December 3, 2025	Executive	Kirberger Marcela A.	December 1, 2025	Sell	1,510	85.56	129,200
December 2, 2025	Executive	Harrington Paul S	December 1, 2025	Sell	4,528	85.56	387,400

[Company Information]

Solventum Corporation was incorporated in Delaware. Solventum is a leading global healthcare company that develops, manufactures, and commercializes a broad portfolio of solutions, leveraging deep expertise in materials science, data science, and digital capabilities to meet critical customer and patient needs. They continuously seek to improve standards of care and drive innovation through insights, clinical intelligence, technology, and manufacturing expertise, advancing healthcare forward.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes